A central pillar of the market's long-term sustainability and global acceptance is the commitment to scientific validation and standardization. Key government bodies, including the Central Council for Research in Ayurvedic Sciences (CCRAS) and the Pharmacopoeial Commission for Indian Medicine & Homoeopathy (PCIM&H), are leading this initiative.

Efforts are focused on:

• Clinical Research: Conducting robust clinical trials (including RCTs and exploratory studies) to generate evidence on the safety, efficacy, and cost-effectiveness of classical Ayurvedic formulations and therapies.

• Standardization: Developing the Ayurvedic Pharmacopoeia of India (API), which serves as the official compendium for quality control, defining consistent parameters for the identity, purity, and strength of raw materials and finished drugs.

• Integrative Research: Employing modern biomedical methodologies to understand the mechanisms of action for traditional practices.

This commitment to evidence-based practice and standardized quality is vital for integrating Ayurveda into mainstream health systems and is essential for maintaining consumer trust and international credibility in the India Ayurvedic Products Market, as outlined in official research mandates, such as the India Ayurvedic Products Market Global Outlook.